Hetal Shah

16PUBLICATIONS
52CO-AUTHORS
Epidemiological modellingCardiology (incl. cardiovascular diseases)Optical technologyMajor global burdens of diseaseAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 06, 2026
Acylcarnitines and prediction of renal function decline in type 2 diabetes.

|Aug 19, 2025
Risk and protective factors for coronary atherosclerosis and myocardial dysfunction in individuals with long-duration type 1 diabetes.

Marc Gregory Yu, Hetal Shah, Surya Jangolla

|Nov 20, 2024
Reduced Aqueous Retinol-Binding Protein 3 Concentration Is Associated With Diabetic Macular Edema and Progression of Diabetic Retinopathy.

Tanvi Chokshi, Ward Fickweiler, Surya Jangolla

|Jan 23, 2024
Poor Glycemic Control Is Associated With More Rapid Kidney Function Decline After the Onset of Diabetic Kidney Disease.

Hetal S Shah, Janet B McGill, Irl B Hirsch

|Jul 19, 2023
Cardiovascular Autonomic Neuropathy and Risk of Kidney Function Decline in Type 1 and Type 2 Diabetes: Findings From the PERL and ACCORD Cohorts.

Yaling Tang, Lynn Ang, Mamta Jaiswal

|Jun 13, 2022
Serum Orotidine: A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies.

Hetal S Shah, Lorena Ortega Moreno, Mario Luca Morieri

Pageof 3

Frequent Collaborators

9 joint publications

Alessandro Doria

5 joint publications

George L King

3 joint publications

Rodica Pop-Busui

3 joint publications

Vincenzo Trischitta